Skip to main content
Overview
News
Events & Presentations
Stock Information
Stock Quote
Stock Chart
Historical Stock Quote
Investment Calculator
Financials
Form 8937
SEC Filings
Governance
Corporate Governance
Management Team
Resources
Information Request Form
Investor Email Alerts
Site Search
Search query
Overview
News
Events & Presentations
Stock Information
Stock Quote
Stock Chart
Historical Stock Quote
Investment Calculator
Financials
Form 8937
SEC Filings
Governance
Corporate Governance
Management Team
Resources
Information Request Form
Investor Email Alerts
Search query
News
Overview
News
Events & Presentations
Stock Information
Stock Quote
Stock Chart
Historical Stock Quote
Investment Calculator
Financials
Form 8937
SEC Filings
Governance
Corporate Governance
Management Team
Resources
Information Request Form
Investor Email Alerts
Normal
Press release year list
2023
2022
2021
2020
2019
2018
03/20/2023
Eterna Therapeutics Reports Financial Results for Fourth Quarter and Full Year 2022 and Recent Business Highlights
02/22/2023
Eterna Therapeutics Enters Into Option and License Agreement with Lineage Cell Therapeutics to Develop Hypoimmune Pluripotent Cell Lines for Multiple Neurology Indications
01/04/2023
Eterna Therapeutics Appoints Matt Angel, Ph.D. as Chief Executive Officer and President